Effect of oral fenofibrate on serum bilirubin level in term neonates with hyperbilirubinemia.
Phase 1
Recruiting
- Conditions
- Hyperbilirubinemia.Physiological jaundice (intense)(prolonged) NOS
- Registration Number
- IRCT2017081635732N1
- Lead Sponsor
- Vice- Chancellor for Research Technology Affairs, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
full-term newborns, with of age of more than 72 hour and serum bilirubin level more than 15 mg/dl.
Exclusion criteria: Preterm infants, IUGR, Congenital anomaly, Respiratory distress, sepsis.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum bilirubin's level. Timepoint: Total serum bilirubin level measured at the time of admission, daily during the hospitalization and at the time of the discharge. Method of measurement: Bilirubin was checked by diazo (Photometr) method by farazkave therapy kits that producing in Iran.
- Secondary Outcome Measures
Name Time Method Duration phototherapy unresponsive to phototherapy, severe hyperbilirubinemia need to exchange. Timepoint: Time of admission and time of discharge. Method of measurement: Auto analyzer.